AA-81-CY65_0.01uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=0.01uM, N-Methyl-beta-carboline-3-carboxamide, GABA(A) BZ Site Receptor Inverse Agonists targeting GABRA1, GABRA2, GABRA3, GABRG2, GABRA5, GABRA4, GABRA6, GABRG1, GABRG3 (Novartis, 4375)
|
| External Link |
https://pubchem.ncbi.nlm.nih.gov/compound/4375
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
21 genes differentially expressed following the AA-81-CY65_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
RPL31
|
ribosomal protein L31
|
0.733639
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
0.697767
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
0.465586
|
|
RPL11
|
ribosomal protein L11
|
0.381249
|
|
RPL37
|
ribosomal protein L37
|
0.381249
|
|
TUBA1B
|
tubulin, alpha 1b
|
0.312288
|
|
SF3B6
|
splicing factor 3b, subunit 6, 14kDa
|
0.305489
|
|
COX7C
|
cytochrome c oxidase subunit VIIc
|
0.265922
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
0.259107
|
|
VAPA
|
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa
|
0.259107
|
|
MYL6
|
myosin, light chain 6, alkali, smooth muscle and non-muscle
|
0.258771
|
|
CDC20
|
cell division cycle 20
|
0.215691
|
|
ECI2
|
enoyl-CoA delta isomerase 2
|
0.215691
|
|
PPDPF
|
pancreatic progenitor cell differentiation and proliferation factor
|
0.209941
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
NLRP4
|
NLR family, pyrin domain containing 4
|
-0.322724
|
|
IST1
|
increased sodium tolerance 1 homolog (yeast)
|
-0.265922
|
|
TM9SF3
|
transmembrane 9 superfamily member 3
|
-0.265922
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
-0.259107
|
|
C6ORF89
|
chromosome 6 open reading frame 89
|
-0.218789
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
-0.218789
|
|
GLYAT
|
glycine-N-acyltransferase
|
-0.200103
|